Article Figures & Tables
Figures
- Fig. 1.
Cellular phenotypes of RTT. (A) hiPSC-derived neurons from RTT patients show decreased soma size. *P<0.0001, Student’s t-test. Adapted from Cheung et al. (Cheung et al., 2011), with permission. (B) RTT-hiPSC-derived neurons have reduced density of excitatory synapses along dendrites compared with neurons derived from healthy controls. The staining shows that hiPSC-derived neurons from RTT patients have fewer VGLUT1-positive glutamatergic synaptic puncta interspersed along MAP2-positive dendrites. (C) Tracking fluorescence intensity changes representing intracellular Ca2+ fluctuations provides evidence of reduced synaptic activity in RTT-hiPSC-derived neurons relative to controls. B and C are adapted from Marchetto et al. (Marchetto et al., 2010), with permission. ROI, region of interest; WT, wild type. Scale bar: 5 μm.
- Fig. 2.
Cellular phenotype of SCZD. Rabies virus transmission between neurons can be used to assay neuronal connectivity. SCZD-hiPSC-derived neurons show decreased transmission of a genetically engineered rabies virus designed specifically to indicate monosynaptic neuronal connectivity (Rabies-EnvAΔG-RFP). Adapted from Brennand et al. (Brennand et al., 2011), with permission. LV-SYNP-HTG, lentivirus expressing a fusion protein comprising histone 2B and green fluorescent protein, TVA and elements of the synapsin (SYN) promoter; used to label neurons for microscopic analysis. Scale bar: 80 μm.
Tables
Article navigation
- Top
- Article
- Abstract
- Introduction
- Reprogramming patient fibroblasts to induced pluripotent stem cells
- Differentiating iPSCs to neurons
- Phenotypes of psychiatric disorders can be identified in hiPSC-derived neurons
- Limitations of hiPSC-based modeling of psychiatric disease
- Direct reprogramming of fibroblasts to neurons
- Conclusion
- Acknowledgements
- Footnotes
- REFERENCES
- Figures & tables
- Info & metrics
Related articles
Cited by...
More in this TOC section
Similar articles
Other journals from The Company of Biologists
Meet the editors
Catch up with Julija Hmeljak, Reviews Editor, at conferences this coming month. Say hello, ask any questions, and find out more about the journal and The Company of Biologists.
Cell Symposia – Gene- and Cell-Based Therapies: CRISPR, Stem Cells, and Beyond
San Francisco, 2-4 March
Stefan Galander, Reviews Editor, will also be at EMBL's Advances in Stem Cells and Regenerative Medicine conference in Heidelberg, 8-11 March.
Hear from this month’s first authors! Eric Clark, Sarah Colijn, Wedad Fallatah, Tara Smith and Cathryn Ugalde talk about their papers and life in science.
Read the latest Editorial, which discusses how blood disorders research is providing a blueprint for successful translation from disease modelling to clinically viable treatment.
Ablation of Bscl2/seipin in hepatocytes does not cause metabolic dysfunction in congenital generalised lipodystrophy
Congenital generalised lypodystrophy patients with BSCL2 mutations develop severe metabolic complications, including hepatic steatosis. But Rochford et al. show that it does not play a cell-autonomous role in regulating lipid accumulation.